Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the ...
The newly formed firm and group are announcing their intention to raise initial bridge financing through offerings under the U.S. SEC's Regulation D and a Hong Kong Stock Exchange (HKEx) debt ...
Nebius Group (NBIS) said it has closed a private offering of convertible senior notes, raising around $4.3B in gross proceeds as the company looks to fund data center build-outs and expand its ...
Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...
Jefferies, Evercore ISI, Citigroup and Guggenheim Securities are acting as joint-book running managers for the Convertible Notes Offering and Equity Offering. Wedbush PacGrow is acting as co-manager ...
(NYSE: WT) ("WisdomTree"), a global financial innovator, today announced its intention to offer, subject to market conditions ...
IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible Notes
$1.0 billion offering of 0.25% convertible senior notes due 2032 $1.0 billion offering of 1.00% convertible senior notes due 2033 $300 million greenshoe fully exercised Capped call transactions ...
Liberty Energy (LBRT) has just completed a US$475 million offering of zero coupon, senior unsecured convertible notes due March 1, 2032, a financing move that puts the company’s capital structure in ...
Shares of Zenas BioPharma fell after the clinical-stage biopharmaceutical company said it commenced an underwritten public offering of notes and stock. The stock slipped 9.8%, to $20, after-hours ...
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results